Home > Insider Trading > Filing (0001209191-13-057634)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1131324	Genomic Health Inc	GHDX	Services-Medical Laboratories (8071)	770552594

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1337334	Steven Shak	301 Penobscot Drive Redwood City CA 94063	Evp Of R&D & Cmo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-12-16	7,000	$2.88	315,283	No	4	M	Direct
Common Stock	Disposition	2013-12-16	7,000	$29.91	308,283	No	4	S	Direct
Common Stock	Acquisiton	2013-12-17	7,000	$2.88	315,283	No	4	M	Direct
Common Stock	Disposition	2013-12-17	7,000	$29.24	308,283	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2013-12-16	7,000	$2.88	7,000	$2.88
Common Stock	Employee Stock Option (right to buy)	Disposition	2013-12-17	7,000	$2.88	7,000	$2.88

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
62,348		2014-12-02	No	4	M	Direct
55,348		2014-12-02	No	4	M	Direct

Footnotes

This sale of common stock was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on September 9, 2013.
Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
Represents weighted average sale price. Actual sale prices ranged from $29.60 to $30.53.
Includes 4,500 restricted stock units awarded January 27, 2011, of which 1/3 of the shares vest on February 15, 2014, and the 1/3 of the shares that vested on each of February 15, 2012 and 2013, net of withholding.
Includes 5,700 restricted stock units awarded February 5, 2012 which vest as to 1/3 of the shares on February 15, 2014 and 2015, and the 1/3 of the shares that vested on February 15, 2013, net of withholding.
Includes 5,000 restricted stock units awarded July 25, 2013, of which 1/3 of the shares vest on each of February 15, 2014, 2015 and 2016.
Represents weighted average sale price. Actual sale prices ranged from $29.00 to $29.97.
The option became exercisable as to 25% of the shares on December 2, 2005, and becomes exercisable as to 1/48th of the shares each full month thereafter.